The Belgian Competition Authority returns a case to the College of Prosecutors for having failed to consider the repeated nature of an abuse of dominance in the pharmaceutical sector (Omega Pharma)

Neyrinck, Norman; Metz, Quentin

Previous article The Mexican Competition Authority issues the highest fine ever against a mobile service provider company for engaging in “relative monopolistic practices” (Telcel) Next article The Croatian Competition Authority finds no abuse of dominance in bundled insurance packages (Croatia osiguranje)

21 Apr 2011

The Belgian Competition Authority returns a case to the College of Prosecutors for having failed to consider the repeated nature of an abuse of dominance in the pharmaceutical sector (Omega Pharma)

KEYWORDS

Reference

Belgian Competition Authority, Omega Pharma, nr. 2011-P/K-13, 21 April 2011 (Dutch)

I. The parties The plaintiff is an independent Belgian dispensing chemist. The defendant is Omega Pharma NV (here after “Omega Pharma”) an important supplier of raw material and packaging products also active in the field of “Over-The-Counter” products (OTC-products). The decision analysed is the second one in this case; the Competition Council already declared the action prescribed in 2010 (decision

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Authors

Norman Neyrinck
Lexing (Liège)

Belgium 20 contributions 15929 visits
Quentin Metz
Pire Asset Management (Charleroi)

3 contributions 2428 visits

Quotation

Norman Neyrinck, Quentin Metz, The Belgian Competition Authority returns a case to the College of Prosecutors for having failed to consider the repeated nature of an abuse of dominance in the pharmaceutical sector (Omega Pharma), 21 April 2011, e-Competitions April 2011, Art. N° 45892

Visites 470